Showing results (51-60 of 55) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2018
Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancerOliver W Hakenberg, Jose Luis Perez-Gracia, Daniel Castellano, et al.American Journal of Cancer Research|December 9, 2017
Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma developmentElzbieta Sarnowska, Michal Szymanski, Nataliia Rusetska, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trialBernard Escudier, Tim Eisen, Walter M Stadler, et al.The New England Journal of Medicine|January 12, 2007
Sorafenib in advanced clear-cell renal-cell carcinomaBernard Escudier, Tim Eisen, Walter M Stadler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trialCora N Sternberg, Daniel P Petrylak, Oliver Sartor, et al.Pageof 6